Endocyte, Inc. (ECYT) Posts Q1 Loss of 11c/Share

Endocyte, Inc. (NASDAQ: ECYT) reported Q1 EPS of ($0.11), $0.05 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $14.24 million.

For earnings history and earnings-related data on Endocyte, Inc. (ECYT) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• TransAlta buys Colorado gas plants for US$1 billion, raises $350 million
• After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,